Atlas Trials

Efficacy and Safety of Eslicarbazepine Acetate as Therapy in Subjects With Fibromyalgia

Clinical trial NCT01820585 · COMPLETED

Trial details

NCT number
NCT01820585
Sponsor
Bial - Portela C S.A.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Fibromyalgia
Start date
2009-04-01
Primary completion
2010-09-01
Enrollment
528

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.